Vagifem Side Effects: What to Expect and When to Call Your Doctor

Vagifem (estradiol vaginal inserts, 10 mcg) is a locally-acting estrogen therapy that delivers a low dose of estradiol directly to vaginal tissue. Because it acts locally with minimal systemic absorption, many of the side effects associated with oral or systemic estrogen therapy are less common with Vagifem. However, side effects do occur, and there are important warning signs every patient should know about.

Vagifem's Boxed Warning: What It Means for You

All estrogen products, including Vagifem, carry an FDA boxed warning — the most serious type of warning the FDA can require on a prescription medication. The boxed warning for Vagifem covers four serious risks:

• Endometrial cancer: Using estrogen without a progestogen in women who still have a uterus increases the risk of endometrial (uterine) cancer. If you have a uterus and are also on systemic estrogen, talk to your provider about whether a progestogen is needed. Note: Vagifem 10 mcg's minimal absorption generally does not require progestogen in most patients when used alone.
• Cardiovascular disorders: The Women's Health Initiative (WHI) estrogen-alone substudy found increased risks of stroke and deep vein thrombosis (DVT). While these risks are primarily associated with systemic estrogen, the boxed warning applies to all estrogen products as a class.
• Probable dementia: The WHIMS estrogen-alone study reported increased risk of probable dementia in postmenopausal women age 65 and older. Again, this applied to systemic estrogen; the clinical significance for low-dose vaginal estrogen is less certain.
• Breast cancer: The estrogen-plus-progestin WHI substudy showed increased risk of invasive breast cancer. For vaginal estrogen alone, the risk relationship is less well-defined.

It's important to understand that while these risks are real for systemic estrogen therapy, Vagifem 10 mcg is a low-dose local vaginal estrogen with very minimal systemic absorption. Many clinicians and The Menopause Society consider it to have a more favorable safety profile than systemic HRT. Discuss your individual risk factors with your provider.

Common Side Effects of Vagifem (≥5% Incidence)

The following side effects occurred in at least 5% of patients in clinical studies:

• Back pain: The most commonly reported side effect in clinical trials. Usually mild and does not require stopping treatment.
• Vulvovaginal pruritus (vaginal itching): Some itching or irritation as vaginal tissue adjusts to the medication. Often improves over the first few weeks of treatment.
• Vulvovaginal mycotic infection (vaginal yeast infection): As estrogen levels in the vagina increase, the local microbiome changes — which can sometimes trigger a yeast infection. Treatable with standard antifungals.
• Diarrhea: Reported in ≥5% of patients, though the mechanism for diarrhea with vaginal administration is not well understood.

Other Reported Side Effects

Additional side effects that have been reported with Vagifem and vaginal estrogen therapy include:

• Headache
• Breast pain or tenderness
• Irregular vaginal bleeding or spotting
• Abdominal cramping or bloating
• Nausea
• Fluid retention (mild edema)
• Hair loss
• Vaginal applicator-related local abrasion (rare, most common in severely atrophic mucosa)

When to Call Your Doctor Right Away

Contact your healthcare provider immediately if you experience any of the following while using Vagifem:

• Unusual vaginal bleeding: Any unexpected vaginal bleeding after menopause may signal endometrial cancer or another serious condition and should be evaluated promptly.
• Breast lump or changes: New lumps, pain, or discharge from the breast should be reported to your provider.
• Sudden vision changes: Sudden loss or blurring of vision may indicate a clot-related eye problem.
• Severe headache: Sudden, severe, or "worst ever" headache could indicate a stroke.
• Chest pain or shortness of breath: These may indicate cardiovascular events like heart attack or blood clot.
• Leg pain or swelling: May signal deep vein thrombosis (DVT).

Who Should Not Use Vagifem?

Vagifem should not be used by people with:

• Undiagnosed abnormal vaginal bleeding
• Known or suspected breast cancer or history of breast cancer
• Known or suspected estrogen-dependent cancers
• Active or history of blood clots (DVT, PE) or arterial thromboembolic disease (stroke, heart attack)
• Liver disease or dysfunction
• Pregnancy

For more on medications that interact with Vagifem, see our guide to Vagifem drug interactions.